HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Hamawaki Selected Research

salicylhydroxamic acid (SHAM)

1/2000Differential effects of pressure or volume overload on myocardial MMP levels and inhibitory control.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Hamawaki Research Topics

Disease

3Pulmonary Hypertension
02/2004 - 09/2000
2Heart Failure
09/2001 - 09/2000
1Neoplasms (Cancer)
03/2004
1Familial Primary Pulmonary Hypertension
02/2004
1Cor Triatriatum (Triatrial Heart)
02/2004
1Scimitar Syndrome
02/2004
1Congenital Heart Defects (Congenital Heart Defect)
09/2001
1Hypovolemia
11/2000
1Left Ventricular Dysfunction
08/2000
1Pathologic Constriction (Stenosis)
08/2000
1Mitral Valve Insufficiency (Mitral Regurgitation)
01/2000
1Rupture
01/2000

Drug/Important Bio-Agent (IBA)

2Atrial Natriuretic Factor (ANF)IBA
09/2001 - 09/2000
1Epoprostenol (Prostacyclin)FDA LinkGeneric
02/2004
1Vasodilator Agents (Vasodilators)IBA
02/2004
1Milrinone (Primacor)FDA LinkGeneric
11/2000
1ColchicineFDA LinkGeneric
08/2000
1Matrix Metalloproteinases (MMPs)IBA
01/2000
1salicylhydroxamic acid (SHAM)IBA
01/2000

Therapy/Procedure

3Therapeutics
02/2004 - 09/2000
1Cardiopulmonary Bypass (Heart-Lung Bypass)
03/2004
1Intravenous Administration
08/2000